Related Experiment Video

Updated: Aug 13, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

FcγRIIb expression in early stage chronic lymphocytic leukemia

Rosa Bosch1,2, Alba Mora1,2, Eva Puy Vicente1,2

  • 1a Laboratory of Oncology/Hematology and Transplantation , Institute of Biomedical Research, IIB Sant Pau , Barcelona , Spain.

Leukemia & Lymphoma
|April 5, 2017
PubMed

Insights

Low expression of Fc gamma receptor IIb (FcγRIIb) on chronic lymphocytic leukemia (CLL) cells may indicate an earlier need for therapy. Further research is needed to confirm FcγRIIb

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • B-cell antigen receptor (BCR) signaling in normal B-cells is regulated by Fc gamma receptor IIb (FcγRIIb).
  • FcγRIIb acts as a negative regulator of BCR signaling.
  • Understanding FcγRIIb's role in chronic lymphocytic leukemia (CLL) is crucial.

Purpose of the Study:

  • To investigate the expression of FcγRIIb in newly-diagnosed Binet A stage CLL patients.
  • To correlate FcγRIIb expression with clinical characteristics and patient outcomes.
  • To assess the prognostic significance of FcγRIIb in CLL.

Main Methods:

  • FcγRIIb expression was measured on 155 newly-diagnosed Binet A CLL patient samples.
  • Expression levels were correlated with established prognostic markers (disease stage, B2M, IGHV, ZAP-70, CD38, cytogenetics).
  • Patient outcomes, including time to therapy, were analyzed based on FcγRIIb expression levels.

Main Results:

  • FcγRIIb expression was similar in normal B-cells and CLL cells, showing heterogeneity among patients and clones.
  • FcγRIIb expression did not correlate with most prognostic markers, except for a weak association with CD49d.
  • Patients with low FcγRIIb expression required therapy earlier (median 151.4 months) compared to those with high expression (not reached).

Conclusions:

  • FcγRIIb expression levels in CLL may have prognostic implications.
  • Lower FcγRIIb expression might be associated with a more aggressive disease course requiring earlier treatment.
  • Further investigation in larger patient cohorts is warranted to confirm the prognostic value of FcγRIIb in CLL.

Keywords:
B-cell activationB-cell receptorChronic lymphocytic leukemiaFcγRIIbtreatment-free survival

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...